Data upload
More 340B entities would share contract pharmacy claims data with manufacturers if the process was better and got 340B pricing turned back on reliably, a survey by McKesson found.

More Entities Might Share 340B Contract Pharmacy Claims Data if the Process Improves and Actually Restores 340B Pricing, Survey Shows

While most 340B covered entities do not share their contract pharmacy claims data with drug makers to restore access to 340B pricing, many would do so if the process was better and got 340B pricing turned back on reliably, a new survey by pharmaceutical distributor McKesson found.

Seventy-two percent of 340B covered entities said in the survey that they do not give their contract pharmacy drug claims data to a drug industry contractor to get 340B pricing back for certain manufacturers’ drugs if the entities want the products to be shipped to multiple contract pharmacies. Of these, however, only 37% were a hard no. Another 34% said either they definitely will report or are considering reporting data but that resources are a barrier.

While most 340B covered entities do not share their contract pharmacy claims data with drug makers to restore access to 340B pricing, many would do so if the process was better and got 340B pricing turned back on reliably, a new survey by pharmaceutical distributor McKesson found.

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.
« Read Previous Read Next »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer